Physician

John R Amrien, M.D.

According to 2025 Medicare claims, John Amrien, M.D. (NPI: 1497757173) practices family practice in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from Salem, NJ. Amrien uses personal NPI as billing NPI and primary practice location at 08079-2053.

Amrien's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 438 traditional Medicare patients, billed 5,493 HCPCS/CPT codes, and received $198,610 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 12,275 prescription claims across 589 beneficiaries totaling $1,376,039 in drug costs, led by Trulicity (Dulaglutide). DME data shows 366 claims. Open Payments data shows 29 records totaling $484. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $292,929 to $198,610. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $38,631 to $39,760.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	661	9,271	$292,929
2016	625	11,105	$356,778
2017	598	10,770	$328,178
2018	588	10,100	$302,810
2019	514	7,649	$258,524
2020	483	4,629	$185,620
2021	420	3,515	$141,991
2022	332	2,589	$112,471
2023	353	2,734	$101,004
2024	438	5,493	$198,610

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	633	12,650	$1,070,232
2016	578	12,902	$1,058,879
2017	575	12,379	$1,078,422
2018	582	12,405	$1,118,615
2019	582	12,909	$1,113,758
2020	578	12,545	$1,104,786
2021	567	12,011	$1,247,953
2022	552	10,934	$1,098,547
2023	567	10,820	$1,221,163
2024	589	12,275	$1,376,039

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	355	1,225	$31,515
2016	388	1,206	$23,336
2017	245	960	$19,512
2018	269	1,007	$21,808
2019	222	960	$35,394
2020	155	780	$30,276
2021	143	540	$14,200
2022	41	268	$9,669
2023	556	867	$2,771,557
2024	45	366	$15,057

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	198	303	$101
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	357	1,047	$67
96372	Injection of drug or substance under skin or into muscle	225	925	$11
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	199	368	$1
J0696	Injection, ceftriaxone sodium, per 250 mg	149	234	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trulicity	Dulaglutide	79	4,370	$134,929
Eliquis	Apixaban	160	6,848	$128,640
Ozempic	Semaglutide	79	3,990	$125,818
Humira Pen	Adalimumab	13	364	$88,554
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	86	3,570	$72,441

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	16	$3,981
K0823	Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds	Y	N/R	19	$2,313
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	34	$1,985
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	18	$1,513
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	23	$1,153

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$484	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John R. Amrien, M.D.?

Tedicare shows public-source Medicare data for John R. Amrien, M.D. (NPI 1497757173), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John R. Amrien, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John R. Amrien, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does John R. Amrien, M.D. have Open Payments data?

John R. Amrien, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.